CymaBay Therapeutics Inc.

(CBAY) Trade

By |

Profile

CymaBay Therapeutics Inc is an American biotechnology enterprise. Its product candidates include Arhalofenate, MBX-8025, and MBX-2982, which are meant to combat serious metabolic diseases.

Contact Information

Website: www.cymabay.com
Email: investors@cymabay.com
Main Phone: +1 510 293-8800
Address: 7999 Gateway Boulevard
Address 2: Suite 130
State: CA
City / Town: Newark
Country: USA
Postal Code: 94560

Issuer Information

Exchange: NGS
CEO: Sujal Shah
Employees: 26
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 13.74 $ -0.11 (-0.79%)
Last Price 13.74 Change $ -0.11 Change % -0.79 Tick N/A
Bid 13.63 Bid Size 200.00 Ask 15.00 Ask Size 600.00
Open 13.83 High 14.09 Low 13.33 Prev Close 13.85
Last Trade Volume 8.1 mi 52 Wk Hi 15.59 52 Wk Low 5.00
Market Cap 807.5 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 58,768,799.00 EPS (TTM) -0.92 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 7 48
Number of Buys 3 20
Number of Sells 4 28
Net Activity -1840 -1402191
Last 10 Buys Shares
Charles A. McWherter 1,000
Charles A. McWherter 1,000
Robert J. Wills 1,000
Robert J. Wills 1,000
Robert J. Wills 1,000
Robert J. Wills 1,000
Charles A. McWherter 1,000
Charles A. McWherter 1,000
Charles A. McWherter 1,000
Sujal Shah 1,000
Last 10 Sell Shares
Kurt von Emster 1,000
Kurt von Emster 1,000
Carl S. Goldfischer 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
Kurt von Emster 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 27 27 27 27
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 20.14 19.86 19.86 20.14
Standard Deviation 3.89 3.72 3.72 3.89
Date of Most Recent Estimate 06/11/18 05/22/18 05/22/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 8 8
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1